hexapeptide-45 hamilelikte güvenli mi?
No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
Related ingredients
Frequently asked questions
- hexapeptide-45 hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications found (ECHA Annex VI) and no SCCS or CIR safety opinion specifically identifying reproductive hazards for hexapeptide-45. No peer‑reviewed reproductive or developmental toxicity studies located in PubMed for this ingredient; as a short peptide it is expected to have low dermal systemic absorption from cosmetic use (PubChem, CosIng). Based on these authoritative absences, default to no evidence of reproductive hazard. (Sources searched: ECHA Annex VI, SCCS, CIR, PubMed, PubChem, CosIng.)
- hexapeptide-45 emzirirken güvenli mi?
- No data or regulatory flags (ECHA Annex VI, SCCS, CIR) indicating hazards for lactation or transfer into breast milk. No studies found in PubMed showing placental or milk transfer for hexapeptide-45; peptides of this size applied topically are generally poorly absorbed systemically (PubChem, CosIng), so breastfeeding exposure is expected to be negligible under normal cosmetic use.
- hexapeptide-45 bebek cildi için güvenli mi?
- No evidence of infant-specific developmental or dermal toxicity (no SCCS/CIR/toxicology studies located). Hexapeptides are relatively large and polar, so adult dermal absorption is expected to be negligible (adult e=0), but because infant skin has higher surface‑area-to‑weight and an immature barrier, increase exposure rating by one (e=1) to reflect low but potentially measurable absorption in 0–3 yr skin. No data indicate increased hazard (h=0) or a specific reproductive mechanism (m=0).
- VeriMom hexapeptide-45 nasıl puanlıyor?
- VeriMom hexapeptide-45'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hexapeptide-45 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.